Male breast carcinoma is an uncommon phenomenon, accounting for less than 1% of all malignancies of the breast. The approximate annual incidence in Europe is 1 in 100,000 cases. The highest incidence occurs 5-10 years later in men than in women, with a peak at 60 to 67 years of age. We here describe a case of male breast carcinoma in a young patient (44 years of age), which is quite unusual in the pattern of breast carcinoma presentation.
LandisS.H.MurrayT.BoldenS.WingoP.A.: Cancer statistics in 1998.CA Cancer J Clin, 48: 6–29, 1998.
2.
AnelliA.AnelliT.F.YoungsonB.RosenP.P.BorgenP.I.: Mutations of the p53 gene in male breast cancer.Cancer, 75: 2233–2238, 1995.
3.
BorgenP.I.WongG.Y.VlamisV.PotterC.HoffmannB.KinneD.W.OsborneM.P.McKinnonW.M.: Current management of male breast cancer, a review of 104 cases.Ann Surg, 215: 451–459, 1992.
4.
HillT.D.KhamisH.J.TyczynskiJ.E.BerkelH.J.: Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival.Ann Epidemiol, 15: 773–780, 2005.
5.
JemalA.MurrayT.WardE.SamuelsA.TiwariR.C.GhafoorA.FeuerE.J.ThunM.J.: Cancer statistics.CA Cancer J Clin, 55: 10–30, 2005.
6.
EwertzM.HolmbergL.KarjalainenS.TretliS.AdamiH.O.: Incidence of male breast cancer in Scandinavia, 1943-1982.Int J Cancer, 43: 27–31, 1989.
7.
La VecchiaC.LeviF.LucchiniF.: Descriptive epidemiology of male breast cancer in Europe.Int J Cancer, 51: 62–66, 1992.
8.
EwertzM.: Epidemiology of breast cancer: the Nordic contribution.Eur J Surg, 162: 97–99, 1996.
9.
GennariR.CuriglianoG.Jereczek-FossaB.A.ZurridaS.RenneG.IntraM.GalimbertiV.LuiniA.OrecchiaR.VialeG.GoldhirschA.VeronesiU.: Male breast cancer: A special therapeutic problem. Anything new? (Review).Int J Oncol, 24: 663–670, 2004.
10.
GiordanoS.H.CohenD.S.BuzdarA.U.PerkinsG.HortobagyiG.N.: Breast carcinoma in men: a population-based study.Cancer, 101: 51–57, 2004.
11.
PetitJ.Y.VeronesiU.OrecchiaR.LuiniA.ReyP.IntraM.DidierF.MartellaS.RietjensM.GarusiC.De LorenziF.GattiG.LeonM.E.CasadioC.: Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.Breast Cancer Res Treat, 96: 47–51, 2006.
12.
ThomasD.B.JimenezL.M.McTiernanA.RosenblattK.StalsbergH.StemhagenA.ThompsonW.D.CurnenM.G.SatarianoW.AustinD.F.: Breast cancer in men: risk factors with hormonal implications.Am J Epidemiol, 135: 734–748, 1992.
13.
DodgeO.G.JacksonA.W.MuldalS.: Breast cancer and interstitial cell tumor in a patient with Klinefelter's syndrome.Cancer, 24: 1027–1032, 1969.
14.
BashamV.M.LipscombeJ.M.WardJ.M.GaytherS.A.PonderB.A.EastonD.F.PharoahP.D.: BRCA1 and BRCA2 mutations in a population-based study of male breast cancer.Breast Cancer Res, 4: R2, 2002.
15.
FriedmanL.S.GaytherS.A.KurosakiT.GordonD.NobleB.CaseyG.PonderB.A.Anton-CulverH.: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.Am J Hum Genet, 60: 313–319, 1997.
16.
KwiatkowskaE.TeresiakM.FilasV.KarczewskaA.BreborowiczD.MackiewiczA.: BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.Clin Cancer Res, 9: 4452–4459, 2003.
17.
GiordanoS.H.: A review of the diagnosis and management of male breast cancer.Oncologist, 10: 471–479, 2005.
18.
CrichlowR.W.: Carcinoma of the male breast.Surg Gynecol Obstet, 134: 1011–1019, 1972.
19.
ErlichmanC.MurphyK.C.ElhakimT.: Male breast cancer: a 13-year review of 89 patients.J Clin Oncol, 2: 903–909, 1984.
20.
StranzlH.MayerR.QuehenbergerF.PrettenhoferU.Will-furthP.StogerH.HacklA.: Adjuvant radiotherapy in male breast cancer.Radiother Oncol53: 29–35, 1999.
